INVO Fertility ( (IVF) ) has released a notification of late filing.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
INVO Fertility, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The company cites the need for additional time to finalize its financial statements as the primary reason for the delay. INVO Fertility expects to file the report within the extension period of 5 calendar days. The company anticipates a significant change in its financial results, with an expected increase in net loss by approximately $1 million compared to the same period last year, primarily due to a noncash loss from debt extinguishment. INVO Fertility is actively working to comply with filing requirements, and the notification was signed by CEO Steve Shum.
The most recent analyst rating on (IVF) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
INVO Fertility’s overall stock score is primarily impacted by its financial performance, which shows revenue growth but significant operational losses and high leverage. Technical analysis indicates a bearish trend with weak momentum. The valuation is poor due to negative earnings and lack of dividends, further weighing down the score.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 4,808,303
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.71M
Learn more about IVF stock on TipRanks’ Stock Analysis page.